149 related articles for article (PubMed ID: 8925541)
1. [Detection of HCV RNA in anti-HCV positive patients with chronic hepatic porphyria].
Malina L; Zdárský E; Havlícková M; Stránský J
Cas Lek Cesk; 1996 Jul; 135(13):427-9. PubMed ID: 8925541
[TBL] [Abstract][Full Text] [Related]
2. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
[TBL] [Abstract][Full Text] [Related]
3. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
Quecedo L; Costa J; Enríquez de Salamanca R
Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
[TBL] [Abstract][Full Text] [Related]
4. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
[TBL] [Abstract][Full Text] [Related]
5. Porphyria cutanea tarda and hepatitis C viral infection. A clinical and virologic study.
Cribier B; Petiau P; Keller F; Schmitt C; Vetter D; Heid E; Grosshans E
Arch Dermatol; 1995 Jul; 131(7):801-4. PubMed ID: 7611796
[TBL] [Abstract][Full Text] [Related]
6. [Chronic hepatic porphyria and hepatitis B and C virus infections].
Malina L; Stránský J; Havlícková M; Zd'árský E
Cas Lek Cesk; 1998 Sep; 137(18):561-4. PubMed ID: 9818466
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of viral hepatitis C in patients with porphyria cutanea tarda].
Malina L; Arenberger P; Kracíková J
Cas Lek Cesk; 1994 Oct; 133(19):599-601. PubMed ID: 7525065
[TBL] [Abstract][Full Text] [Related]
8. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.
Bode JC; Alscher DM; Wisser H; Bode C
Alcohol Alcohol; 1995 Jan; 30(1):97-103. PubMed ID: 7748281
[TBL] [Abstract][Full Text] [Related]
9. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers.
Papatheodoridis GV; Delladetsima J; Verghisi-Nikolakaki S; Malliori M; Krystallis A; Hatzakis A; Tassopoulos NC
Am J Gastroenterol; 1995 Oct; 90(10):1843-6. PubMed ID: 7572906
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of IgM anti-HCV determination in chronic hepatitis C].
Stránský J; Krtek V; Honzáková E; Vandasová J; Mand'áková Z; Kyncl J; Nĕmecek V
Cas Lek Cesk; 1996 Apr; 135(7):215-9. PubMed ID: 8681370
[TBL] [Abstract][Full Text] [Related]
13. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
[TBL] [Abstract][Full Text] [Related]
16. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
17. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.
Fabrizi F; Lunghi G; Marai P; Marcelli D; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
Nephrol Dial Transplant; 1996 Jan; 11(1):159-64. PubMed ID: 8649626
[TBL] [Abstract][Full Text] [Related]
18. [Porphyria cutanea tarda and hepatitis C virus infection. Clinical and virological study].
Cribier B; Petiau P; Stoll-Keller F; Schmitt C; Vetter D; Heid E; Grosshans E
Ann Dermatol Venereol; 1996; 123(3):200-2. PubMed ID: 8761787
[TBL] [Abstract][Full Text] [Related]
19. [Association of porphyria cutanea tarda and hepatitis C virus].
Martín-Vivaldi Martínez R; Espinosa Aguilar MD; Sánchez Sanchéz-Vizcaíno J; Quintero Fuentes D; Nogueras López F; López de Hierro Ruiz M
Rev Esp Enferm Dig; 1996 Mar; 88(3):213-6. PubMed ID: 8645516
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
